DNAnexus Wins Five-Year, $20M Contract to Power precisionFDA Platform

Enhancements include upgrading the platform’s sponsor-reviewer interaction, adding support for multi-omics, and offering a library of analytical, statistical, and machine learning applications that are both accessible to reviewers and sufficiently powerful for bioinformaticians.
DNA Binary

Illumina, Emedgene Partnership to Automate AI-Driven Data Analysis for Rare Diseases

The companies say that through AI-enhanced interrogation of medical literature and phenotypes associated with rare disease, researchers will be better able to make new and unexpected discoveries based on rare disease data.
elderly man with head breaking apart

Feasibility Study Finds Informative Digital Biomarkers of Dementia

Combining wearable devices, handheld devices and digital apps lets researchers tell the difference between people with early dementia and those without it.
Doctor's Appointment

NorthShore Taps Sema4 in Launch of System-Wide Genomics Program

Already a leader among U.S. health systems in using genomics to guide care, the strategic alliance between NorthShore and Sema4 will significantly expand NorthShore’s existing clinical genomics offerings to more than 1,000 physicians and approximately 300,000 NorthShore patients.
Senior holding smartphone, using fitness app

The DNA Company Buys AI-Driven Pain App for $30M, Forms New Venture

The intention is to use the combined expertise in functional genomics and digital therapeutics to develop a range of health apps with pain management and COVID-19 the initial foci.
Electronic Health Record

Irish Researchers Integrate Epilepsy Genomics into Electronic Patient Records

Researchers in Ireland are one step closer to offering seamless personalized care to epilepsy patients nationwide, reporting that they have developed a genomics module...
New data describes the economic impact of genomic sequencing procedures. [NIH]

GA4GH Details its COVID-19 Patient Data Sharing, Privacy Recommendations

GA4GH says its goal is to summarize key regulatory pathways, particularly providing information on health research regulation and ethical/legal data governance, including possible modification for genomic researchers in a public health emergency.
Vanderbilt University Medical Center (VUMC) has formed Nashville Biosciences

VUMC Spinout to Apply Genomic Data toward Precision Drugs, Diagnostics

Nashville Biosciences will leverage resources that include BioVU biorepository of DNA samples coupled with de-identified patient records

Largest Study to Date of COVID-19 Susceptibility Launched

Researchers will launch the study involving 1,000 subjects—consisting of COVID-19 patients and their partners and first-degree relatives as controls—to compare a variety of genomic and other biological variables between those patients who show no or mild symptoms and those who show severe illness.
Black doctor using digital display

The Age of Analytics: Sequencing’s New Frontier Is Clinical Interpretation

David FitzPatrick’s typical patient is a toddler with global developmental delay who is small for her age, has epilepsy, and cannot speak or understand...


Scroll Up